Ataxia telangiectasia overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Neurology]] | |||
[[Category:Genetic disorders]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:06, 29 November 2012
Ataxia telangiectasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ataxia telangiectasia overview On the Web |
American Roentgen Ray Society Images of Ataxia telangiectasia overview |
Risk calculators and risk factors for Ataxia telangiectasia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ataxia-telangiectasia (AT) is a primary immunodeficiency disorder. It is associated with a defect in T-cells.[1]
References
- ↑ "Ataxia-Telangiectasia: Immunodeficiency Disorders: Merck Manual Professional". Retrieved 2008-03-01.